Summary
Symbiotec Pharmalab has set the price band for its Rs 1,757 crore IPO, which will open for subscription from August 24 to August 27, 2026. The biopharmaceutical company aims to strengthen its balance sheet and use proceeds for debt repayment and general corporate purposes.